Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

The recent insider selling of Ultragenyx Pharmaceutical shar...

The recent insider selling of Ultragenyx Pharmaceutical shares, despite the high level of insider ownership, raises caution. The lack of insider buying in the last twelve months also adds to this concern.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
1
+0
Translate
Report
6400 Views
Comment
Sign in to post a comment